+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Is it possible to diagnose primary anti-phospholipid syndrome (PAPS) on the basis of renal thrombotic microangiopathy (PAPS nephropathy) in the absence of other thrombotic process?

Is it possible to diagnose primary anti-phospholipid syndrome (PAPS) on the basis of renal thrombotic microangiopathy (PAPS nephropathy) in the absence of other thrombotic process?

Renal Failure 25(6): 1043-1049

The kidneys are a major target of PAPS. The histologic lesions of PAPS nephropathy are vascular; among them thrombotic microangiopathy (TMA) is the most characteristic. It is still not clear in the literature whether the nephropathy can be the unique manifestation of PAPS in the absence of other thrombotic processes; that is: do the renal microthrombotic lesions allow to make the diagnosis of PAPS in presence of anti-phospholipid antibodies (APA)? With this purpose we present three clinical cases. The first patient had severe hypertension C4 hypocomplementemia, thrombocytopenia, and mitralic valve insufficiency. LAC and anti-cardiolipin antibodies at high titre were positive. The histologic picture was characterized by basement membrane reduplication and arteriolar mucoid degeneration, which are features of early phase of TMA. The second patient had severe hypertension. The detection of anti-cardiolipin antibodies was performed several times and resulted positive three times, four months after the diagnosis as well. The renal histologic features were consistent with late lesions of TMA. The third patient had severe hypertension, rapidly progressive renal failure, tricuspidal valve insufficiency and two positive anti-phospholipid antibodies determinations three weeks apart (in two occasions anti-cardiolipin and in one occasion LAC as well were found). The renal lesions were characteristic for TMA. In conclusion we think that patients with TMA and antiphospholipid antibodies can be considered affected by PAPS, as the thrombotic process is represented by thrombosis in preglomerular arterioles, which leads to TMA.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 068800566

Download citation: RISBibTeXText

PMID: 14669864

DOI: 10.1081/jdi-120026040

Related references

Is It Possible to Diagnose Primary Anti-phospholipid Syndrome (Paps) on the Basis of Renal Thrombotic Microangiopathy (Paps Nephropathy) in the Absence of Other Thrombotic Process?. Renal Failure 25(6): 1043-1049, 2003

Is it possible to diagnose primary anti-phospholipid syndrome on the basis of renal thrombotic microangiopathy in the absence of other thrombotic process?. Renal Failure 25(6): 1043-1049, 2003

Primary antiphospholipid syndrome paps associated with renal thrombotic microangiopathy tma report of 4 cases. Journal of the American Society of Nephrology 2(3): 267, 1991

Recurrent renal thrombotic angiopathy after kidney transplantation in two patients with primary antiphospholipid syndrome (PAPS). Clinical Transplantation 8(2 Pt 1): 93-96, 1994

De novo thrombotic microangiopathy in renal transplant recipients: a comparison of hemolytic uremic syndrome with localized renal thrombotic microangiopathy. American Journal of Kidney Diseases 41(2): 471-479, 2003

A "primary" thrombotic syndrome: absence of anti-phospholipid antibodies. Clinical Rheumatology 10(1): 81-83, 1991

Anti-argonaute2 (Ago2/Su) and -Ro antibodies identified by immunoprecipitation in primary anti-phospholipid syndrome (PAPS). Autoimmunity 44(2): 90-97, 2011

Anti-argonaute 2 (Ago2/Su) and -Ro antibodies are the common autoantibody specificities in primary anti-phospholipid syndrome (PAPS). Annals of the Rheumatic Diseases 69(Suppl 2): A3-A3, 2010

Sneddon's syndrome and primary anti-phospholipid syndrome (PAPS). British Journal of Dermatology 122(1): 115-116, 1990

Anti-annexin V antibodies as a risk factor of thrombotic events and fetal loss in sera of SLE, PAPS and SAPS patients. Reumatologia 41(1): 12-24, 2003

Renal thrombotic microangiopathy and antiphospholipid syndrome nephropathy in a patient with lupus nephritis. Nihon Jinzo Gakkai Shi 58(1): 45-54, 2016

Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy. Lancet. Haematology 3(5): E237-E245, 2016

Contribution of anti-β2glycoprotein I IgA antibodies to the diagnosis of anti-phospholipid syndrome: potential interest of target domains to discriminate thrombotic and non-thrombotic patients. Rheumatology 53(7): 1215-1218, 2014

Anti dna antibodies in the primary antiphospholipid syndrome paps. British Journal of Rheumatology 31(Suppl. 1): 5, 1992

Anti-DNA antibodies in the primary antiphospholipid syndrome (PAPS). British Journal of Rheumatology 32(5): 362-365, 1993